Exchanges
BSE, NSE
Issue
Book building

Persistent Systems IPO

₹406.35

+31.08% on listing

Listing-day close · NSE · 6 Apr 2010 · issue price ₹310

Persistent Systems’ ₹168 crore IPO was priced at ₹310 a share. It listed on the NSE on 6 Apr 2010 and closed its first day at ₹406.35, up 31.08% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Listing

Issue details

Issue size
₹168 Cr
Fresh issue
₹128 Cr
Offer for sale
₹39.70 Cr
Lot size
20 shares
Minimum investment
₹6,200
Face value
₹10
Registrar
MUFG Intime India

Subscription

Persistent Systems IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—92.87×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹1,240 Cr
ROE
18.50%
ROCE
42.80%
Promoter holding
43.34% → 0.39%

From the offer documents.

Listing

Listing date
6 Apr 2010
Issue price
₹310
Open
₹361.60
High
₹447.30
Low
₹361.60
Close
₹406.35

Listing day on the NSE. The close was +31.08% on the issue price.

PERSISTENT share price today

FAQs

When did the Persistent Systems IPO open and close?

It opened on 17 Mar 2010 and closed on 19 Mar 2010.

What was the Persistent Systems IPO price?

The price band was ₹290–310 a share. The final issue price was ₹310.

What is the lot size and minimum investment?

One lot is 20 shares, ₹6,200 at ₹310 a share. Retail investors apply in whole lots.

How much did Persistent Systems raise?

₹168 crore: ₹128 crore of new shares and ₹39.70 crore offered by existing shareholders.

How many times was the Persistent Systems IPO subscribed?

92.87 times overall.

How did Persistent Systems list?

It listed on the NSE on 6 Apr 2010 at ₹361.60 and closed the day at ₹406.35, up 31.08% on the ₹310 issue price.

Who is the registrar of the Persistent Systems IPO?

MUFG Intime India handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app